Molecular genetics of the stress-responsive adrenocortical axis

Annals of Medicine

Volumn 40, Issue 2, 2008, Pages 139-148

  Redei, Eva E ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Adrenal cortex; Corticosterone; Cortisol; Metabolic syndrome X; Obesity; Polygenic inheritance; Quantitative trait loci; Stress

Indexed keywords

ALDOSTERONE SYNTHASE; ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; RGS4 PROTEIN; TRANSCORTIN;

ADRENAL CORTEX; GENETIC LINKAGE; GENETIC VARIABILITY; HOMEOSTASIS; INDIVIDUALITY; METABOLIC SYNDROME X; MOLECULAR GENETICS; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; STRESS;

ACUTE DISEASE; ADAPTATION, PHYSIOLOGICAL; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CHRONIC DISEASE; GENE ORDER; HUMANS; HYPERPLASIA; HYPERTROPHY; HYPOTHALAMIC HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOLECULAR BIOLOGY; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL; VARIATION (GENETICS);

EID: 43149096919     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890701724863     Document Type: Review

References (103)

1. Rosmond R, Bjorntorp P. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men. J Hypertens. 1998;16:1721-6.
2. Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry. 1999;156:837-41.
3. Kendler KS, Gardner CO, Neale MC, Prescott CA. Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes? Psychol Med. 2001;31:605-16.
4. Sternberg EM. Emotions and disease: from balance of humors to balance of molecules. Nat Med. 1997;3:264-7.
5. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. [See comments]. Nat Neurosci. 1998;1:69-73. Erratum in: Nat Neurosci. 1998;1:329.
6. Piazza PV, Le Moal M. The role of stress in drug self-administration. Trends Pharmacol Sci. 1998;19:67-74.
7. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
8. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-55.
9. Selye H. The Stress of Life. New York: McGraw-Hill Book Company, 1956.
10. Selye H. Thymus and adrenals in the response of the organism to injuries and intoxications. Br J Exp Pathol. 1936;17:234-48.
11. Selye H. Forty years of stress research: principal remaining problems and misconceptions. Can Med Assoc J. 1976;115:53-6.
12. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093-101.
13. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;43:2-15.
14. McEwen BS. Mood disorders and allostatic load. Biol Psychiatry. 2003;54:200-7.
15. McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2004;1032:1-7.
16. McEwen BS. Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain. Metabolism. 2005;54:20-3.
17. Fuchs E, Flugge G. Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci Biobehav Rev. 1998;23:295-300.
18. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57:925-35.
19. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617-25.
20. Pecoraro N, Dallman MF, Warne JP, Ginsberg AB, Laugero KD, la Fleur SE, et al. From Malthus to motive: how the HPA axis engineers the phenotype, yoking needs to wants. Prog Neurobiol. 2006;79:247-340.
21. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53:865-71.
22. Young EA, Abelson J, Lightman SL. Cortisol pulsatility and its role in stress regulation and health. Front Neuroendocrinol. 2004;25:69-76.
23. Kaneko M, Hiroshige T, Shinsako J, Dallman MF. Diurnal changes in amplification of hormone rhythms in the adrenocortical system. Am J Physiol. 1980;239:R309-16.
24. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res. 1987;43:113-73.
25. Bornstein SR, Chrousos GP. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab. 1999;84:1729-36.
26. Buijs RM, Hermes MH, Kalsbeek A. The suprachiasmatic nucleus- paraventricular nucleus interactions: a bridge to the neuroendocrine and autonomic nervous system. Prog Brain Res. 1998;119:365-82.
27. Dallman MF, Engeland WC, Rose JC, Wilkinson CW, Shinsako J, Siedenburg F. Nycthemeral rhythm in adrenal responsiveness to ACTH. Am J Physiol. 1978;235:R210-8.
28. Jasper MS, Engeland WC. Splanchnic neural activity modulates ultradian and circadian rhythms in adrenocortical secretion in awake rats. Neuroendocrinology. 1994;59:97-109.
29. Sage D, Maurel D, Bosler O. Corticosterone-dependent driving influence of the suprachiasmatic nucleus on adrenal sensitivity to ACTH. Am J Physiol Endocrinol Metab. 2002;282:E458-65.
30. Armario A. The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors? CNS Neurol Disord Drug Targets. 2006;5:485-501.
31. Chrousos GP. Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity - a dynamic digital-to-analog modulation. Endocrinology. 1998;139:437-40.
32. Aguilera G, Kiss A, Lu A, Camacho C. Regulation of adrenal steroidogenesis during chronic stress. Endocr Res. 1996;22:433-43.
33. Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab. 2006;291:E965-73.
34. Zelena D, Mergl Z, Foldes A, Kovacs KJ, Toth Z, Makara GB. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint. Am J Physiol Endocrinol Metab. 2003;285:E1110-7.
35. Bicknell AB. Identification of the adrenal protease that cleaves pro-gamma-MSH: the dawning of a new era in adrenal physiology? J Endocrinol. 2002;172:405-10.
36. Willenberg HS, Bornstein SR, Dumser T, Ehrhart-Bornstein M, Barocka A, Chrousos GP, et al. Morphological changes in adrenals from victims of suicide in relation to altered apoptosis. Endocr Res. 1998;24:963-7.
37. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, et al. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab. 1998;83:47-54.
38. Kirschbaum C, Wust S, Faig HG, Hellhammer DH. Heritability of cortisol responses to human corticotropin-releasing hormone, ergometry, and psychological stress in humans. J Clin Endocrinol Metab. 1992;75:1526-30.
39. Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 1998;83:1806-9.
40. Bergendahl M, Iranmanesh A, Mulligan T, Veldhuis JD. Impact of age on cortisol secretory dynamics basally and as driven by nutrient-withdrawal stress. J Clin Endocrinol Metab. 2000;85:2203-14.
41. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996;81:2468-73.
42. Kendler KS. The diagnostic validity of melancholic major depression in a population-based sample of female twins. Arch Gen Psychiatry. 1997;54:299-304.
43. Fergusson DM, Horwood LJ. Vulnerability to life events exposure. Psychol Med. 1987;17:739-49.
44. Bartels M, Van den Berg M, Sluyter F, Boomsma DI, de Geus EJ. Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology. 2003;28:121-37.
45. Wust S, Federenko IS, van Rossum EF, Koper JW, Kumsta R, Entringer S, et al. A psychobiological perspective on genetic determinants of hypothalamus-pituitary-adrenal axis activity. Ann N Y Acad Sci. 2004;1032:52-62.
46. Feitosa MF, Rice T, Rosmond R, Borecki IB, An P, Gagnon J, et al. A genetic study of cortisol measured before and after endurance training: the HERITAGE Family Study. Metabolism. 2002;51:360-5.
47. Armario A, Gavalda A, Marti J. Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology. 1995;20:879-90.
48. Sarrieau A, Chaouloff F, Lemaire V, Mormede P. Comparison of the neuroendocrine responses to stress in outbred, inbred and F1 hybrid rats. Life Sci. 1998;63:87-96.
49. Marissal-Arvy N, Mormede P, Sarrieau A. Strain differences in corticosteroid receptor efficiencies and regulation in Brown Norway and Fischer 344 rats. J Neuroendocrinol. 1999;11:267-73.
50. Redei E, Pare WP, Aird F, Kluczynski J. Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer. Am J Physiol. 1994;266:R353-60.
51. Cui ZH, Ikeda K, Kawakami K, Gonda T, Nabika T, Masuda J. Exaggerated response to restraint stress in rats congenic for the chromosome 1 blood pressure quantitative trait locus. Clin Exp Pharmacol Physiol. 2003;30:464-9.
52. Buitenhuis AJ, Rodenburg TB, van Hierden YM, Siwek M, Cornelissen SJ, Nieuwland MG, et al. Mapping quantitative trait loci affecting feather pecking behavior and stress response in laying hens. Poult Sci. 2003;82:1215-22. Erratum in: Poult Sci. 2006;85:1115-6.
53. Desautes C, Bidanelt JP, Milant D, Iannuccelli N, Amigues Y, Bourgeois F, et al. Genetic linkage mapping of quantitative trait loci for behavioral and neuroendocrine stress response traits in pigs. J Anim Sci. 2002;80:2276-85.
54. Roberts AJ, Phillips TJ, Belknap JK, Finn DA, Keith LD. Genetic analysis of the corticosterone response to ethanol in BXD recombinant inbred mice. Behav Neurosci. 1995;109:1199-208.
55. Kurina LM, Weiss LA, Graves SW, Parry R, Williams GH, Abney M, et al. Sex differences in the genetic basis of morning serum cortisol levels: genome-wide screen identifies two novel loci specific to women. J Clin Endocrinol Metab. 2005;90:4747-52.
56. Ober C, Abney M, McPeek MS. The genetic dissection of complex traits in a founder population. Am J Hum Genet. 2001;69:1068-79.
57. Ukkola O, Rankinen T, Gagnon J, Leon AS, Skinner JS, Wilmore JH, et al. A genome-wide linkage scan for steroids and SHBG levels in black and white families: the HERITAGE Family Study. J Clin Endocrinol Metab. 2002;87:3708-20.
58. Harper JM, Galecki AT, Burke DT, Pinkosky SL, Miller RA. Quantitative trait loci for insulin-like growth factor I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice. Physiol Genomics. 2003;15:44-51.
59. Potenza MN, Brodkin ES, Joe B, Luo X, Remmers EF, Wilder RL, et al. Genomic regions controlling corticosterone levels in rats. Biol Psychiatry. 2004;55:634-41.
60. Solberg LC, Baum AE, Ahmadiyeh N, Shimomura K, Li R, Turek FW, et al. Genetic analysis of the stress-responsive adrenocortical axis. Physiol Genomics. 2006;27:362-9.
61. Badr FM, Spickett SG. Genetic variation in adrenal weight in young adult mice. J Endocrinol. 1971;49:105-11.
62. Valdar W, Solberg LC, Gauguier D, Cookson WO, Rawlins JN, Mott R, et al. Genetic and environmental effects on complex traits in mice. Genetics. 2006;174:959-84.
63. Llamas B, Contesse V, Guyonnet-Duperat V, Vaudry H, Mormede P, Moisan MP. QTL mapping for traits associated with stress neuroendocrine reactivity in rats. Mamm Genome. 2005;16:505-15.
64. Garlow SJ, Boone E, Li W, Owens MJ, Nemeroff CB. Genetic analysis of the hypothalamic corticotropin-releasing factor system. Endocrinology. 2005;146:2362-8.
65. Wellcome Trust Case Control Consortium, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-78.
66. Lipska BK, Mitkus S, Caruso M, Hyde TM, Chen J, Vakkalanka R, et al. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Hum Mol Genet. 2006;15:2804-12.
67. Breuner CW, Orchinik M. Plasma binding proteins as mediators of corticosteroid action in vertebrates. J Endocrinol. 2002;175:99-112.
68. Guyonnet-Duperat V, Geverink N, Plastow GS, Evans G, Ousova O, Croisetiere C, et al. Functional implication of an Arg307Gly substitution in corticosteroid-binding globulin, a candidate gene for a quantitative trait locus associated with cortisol variability and obesity in pig. Genetics. 2006;173:2143-9.
69. Smith CL, Hammond GL. An amino acid substitution in biobreeding rat corticosteroid binding globulin results in reduced steroid binding affinity. J Biol Chem. 1991;266:18555-9.
70. Joyner JM, Hutley LJ, Bachmann AW, Torpy DJ, Prins JB. Greater replication and differentiation of preadipocytes in inherited corticosteroid-binding globulin deficiency. Am J Physiol Endocrinol Metab. 2003;284:E1049-54.
71. Fernandez-Real JM, Grasa M, Casamitjana R, Pugeat M, Barret C, Ricart W. Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion. J Clin Endocrinol Metab. 1999;84:3192-6.
72. Fernandez-Real JM, Pugeat M, Emptoz-Bonneton A, Ricart W. Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid binding globulin in lean, obese, and obese subjects with glucose intolerance. Metabolism. 2001;50:1248-52.
73. Fernandez-Real JM, Pugeat M, Lopez-Bermejo A, Bornet H, Ricart W. Corticosteroid-binding globulin affects the relationship between circulating adiponectin and cortisol in men and women. Metabolism. 2005;54:584-9.
74. Ousova O, Guyonnet-Duperat V, Iannuccelli N, Bidanel JP, Milan D, Genet C, et al. Corticosteroid binding globulin: a new target for cortisol-driven obesity. Mol Endocrinol. 2004;18:1687-96.
75. Wang M. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr Metab (Lond). 2005;2:3.
76. Antonijevic IA, Murck H, Bohlhalter S, Frieboes RM, Holsboer F, Steiger A. Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacol. 2000;39:1474-81.
77. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides. 2004;38:213-24.
78. Heilig M, Thorsell A. Brain neuropeptide Y (NPY) in stress and alcohol dependence. Rev Neurosci. 2002;13:85-94.
79. Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, Rosenheck RA, et al. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch Gen Psychiatry. 2002;59:825-31.
80. Morgan CA 3rd, Rasmusson AM, Wang S, Hoyt G, Hauger RL, Hazlett G. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol Psychiatry. 2002;52:136-42.
81. Jaakkola U, Koulu M, Karvonen MK, Seppala H, Pesonen U, Vahlberg T, et al. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes. Exp Clin Endocrinol Diabetes. 2007;115:281-6.
82. Ukkola O, Kesaniemi YA. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects. Eur J Clin Nutr. 2007;61:1102-5.
83. Ardati A, Goetschy V, Gottowick J, Henriot S, Valdenaire O, Deuschle U, et al. Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacol. 1999;38:441-8.
84. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet. 2000;24:410-4.
85. Muller MB, Preil J, Renner U, Zimmermann S, Kresse AE, Stalla GK, et al. Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation. Endocrinology. 2001;142:4150-3.
86. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998;19:101-43. Erratum in: Endocr Rev. 1998;19:301.
87. Rosmond R, Chagnon YC, Chagnon M, Perusse L, Bouchard C, Bjorntorp P. A polymorphism of the 5′-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism. 2000;49:1197-9.
88. Koper JW, Stolk RP, de Lange P, Huizenga NA, Molijn GJ, Pols HA, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet. 1997;99:663-8.
89. Jewell CM, Cidlowski JA. Molecular Evidence for a Link between the N363S Glucocorticoid Receptor Polymorphism and Altered Gene Expression. J Clin Endocrinol Metab. 2007;92:3268-77.
90. Meaney MJ, Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci. 2005;7:103-23.
91. Davies E, Holloway CD, Ingram MC, Friel EC, Inglis GC, Swan L, et al. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf). 2001;54:813-7.
92. Keavney B, Mayosi B, Gaukrodger N, Imrie H, Baker M, Fraser R, et al. Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J Clin Endocrinol Metab. 2005;90:1072-7.
93. Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ, et al. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension. 2007;49:704-11.
94. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352:1138-45.
95. Chang YT, Kappy MS, Iwamoto K, Wang J, Yang X, Pang S. Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. Pediatr Res. 1993;34:698-700.
96. Rheaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, et al. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat Genet. 1992;1:239-45.
97. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, et al. Two G protein oncogenes in human endocrine tumors. Science. 1990;249:655-9.
98. Tee MK, Lin D, Sugawara T, Holt JA, Guiguen Y, Buckingham B, et al. T - > A transversion 11 bp from a splice acceptor site in the human gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. Hum Mol Genet. 1995;4:2299-305.
99. Pascoe L, Curnow KM, Slutsker L, Rosler A, White PC. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A. 1992;89:4996-5000.
100. Lloyd-MacGilp SA, Torielli L, Bechtel S, Tripodi G, Gomez-Sanchez CE, Zagato L, et al. Mutations in aldosterone synthase gene of Milan hypertensive rats: phenotypic consequences. Am J Physiol Endocrinol Metab. 2002;282:E608-17.
101. Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet. 2000;67:1563-8.
102. Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, et al. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab. 2002;87:4324-9.
103. Marissal-Arvy N, Lombes M, Petterson J, Moisan MP, Mormede P. Gain of function mutation in the mineralo-corticoid receptor of the Brown Norway rat. J Biol Chem. 2004;279:39232-9.